Lpl Financial LLC Bristol Myers Squibb CO Transaction History

Lpl Financial LLC

$196 Billion
Q2 2024

A detailed history of Lpl Financial LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Lpl Financial LLC holds 2,966,771 shares of BMY stock, worth $151 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

2,966,771

Previous 2,437,648 21.71%

Holding current value

$151 Million

Previous $132 Million 6.8%

% of portfolio

0.06%

Previous 0.07%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$40.25 - $52.99 $21.3 Million - $28 Million	529,123 Added 21.71%	2,966,771 $123 Million
Q1 2024 May 10, 2024	BUY	$47.98 - $54.4 $25.6 Million - $29 Million	533,070 Added 27.99%	2,437,648 $132 Million
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $5.89 Million - $7.03 Million	-121,474 Reduced 6.0%	1,904,578 $97.7 Million
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $4.22 Million - $4.72 Million	72,947 Added 3.73%	2,026,052 $118 Million
Q2 2023 Jul 31, 2023	BUY	$63.71 - $70.74 $8.36 Million - $9.29 Million	131,293 Added 7.21%	1,953,105 $125 Million
Q1 2023 May 10, 2023	BUY	$65.71 - $74.53 $14.7 Million - $16.7 Million	224,031 Added 14.02%	1,821,812 $126 Million
Q4 2022 Feb 07, 2023	SELL	$68.48 - $81.09 $4.39 Million - $5.19 Million	-64,039 Reduced 3.85%	1,597,781 $115 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $3,932 - $2.32 Million	-30,252 Reduced 1.79%	1,661,820 $118 Million
Q2 2022 Aug 12, 2022	BUY	$72.62 - $79.98 $4.87 Million - $5.36 Million	67,035 Added 4.13%	1,692,072 $130 Million
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $10.8 Million - $13 Million	176,074 Added 12.15%	1,625,037 $119 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $8.99 Million - $10.5 Million	167,661 Added 13.09%	1,448,963 $90.3 Million
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $3.37 Million - $3.95 Million	57,017 Added 4.66%	1,281,302 $75.8 Million
Q2 2021 Aug 13, 2021	BUY	$61.91 - $67.42 $3.99 Million - $4.34 Million	64,427 Added 5.55%	1,224,285 $81.8 Million
Q1 2021 May 14, 2021	BUY	$59.34 - $66.74 $3.14 Million - $3.53 Million	52,858 Added 4.77%	1,159,858 $73.2 Million
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $5.53 Million - $6.27 Million	95,811 Added 9.48%	1,107,000 $68.7 Million
Q3 2020 Nov 09, 2020	BUY	$57.43 - $63.64 $5.75 Million - $6.37 Million	100,138 Added 10.99%	1,011,189 $61 Million
Q2 2020 Aug 13, 2020	BUY	$54.82 - $64.09 $7.25 Million - $8.47 Million	132,219 Added 16.98%	911,051 $53.6 Million
Q1 2020 May 14, 2020	BUY	$46.4 - $67.43 $1 Million - $1.46 Million	21,657 Added 2.86%	778,832 $43.4 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $6.96 Million - $9.08 Million	141,389 Added 22.96%	757,175 $48.6 Million
Q3 2019 Nov 13, 2019	SELL	$42.77 - $50.71 $476,971 - $565,517	-11,152 Reduced 1.78%	615,786 $31.2 Million
Q2 2019 Aug 09, 2019	BUY	$44.62 - $49.34 $1.66 Million - $1.83 Million	37,124 Added 6.29%	626,938 $28.4 Million
Q1 2019 May 08, 2019	BUY	$45.12 - $53.8 $2.83 Million - $3.38 Million	62,821 Added 11.92%	589,814 $28.1 Million
Q4 2018 Feb 07, 2019	SELL	$48.76 - $63.23 $58,609 - $76,002	-1,202 Reduced 0.23%	526,993 $27.4 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $589,649 - $665,079	-10,684 Reduced 1.98%	528,195 $32.8 Million
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $586,905 - $731,512	11,615 Added 2.2%	538,879 $29.8 Million
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $20,672 - $23,798	-345 Reduced 0.07%	527,264 $33.3 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $2.76 Million - $3.01 Million	46,114 Added 9.58%	527,609 $32.3 Million
Q3 2017 Nov 14, 2017	SELL	$55.23 - $63.74 $367,721 - $424,380	-6,658 Reduced 1.36%	481,495 $30.7 Million
Q2 2017 Aug 14, 2017	BUY	N/A	488,153	488,153 $27.2 Million

Others Institutions Holding BMY

# of Institutions

2,400

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $108B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Bristol Myers Squibb CO Transaction History